Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA.
Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Transl Behav Med. 2020 Aug 7;10(3):657-663. doi: 10.1093/tbm/ibz077.
Technology-assisted cognitive-behavioral therapy (CBT) interventions have been conducted for symptoms including depression, pain, and fatigue in patients with chronic illnesses but not in end-stage renal disease (ESRD). The purpose of this study was to pilot the feasibility and acceptability of a technology-assisted CBT intervention in ESRD patients on hemodialysis (HD), share design and implementation lessons learned, and provide preliminary results on changes in select patient-reported symptoms. This was a single-center pilot feasibility study of adult ESRD patients on HD. Study eligibility required clinically elevated levels of at least one symptom (depression, pain, or fatigue). Patients met weekly with a CBT therapist for eight sessions, each 45-60 min, during HD sessions via a video-conferencing platform. Symptom questionnaires were completed at baseline and 3 months follow-up. Of 10 patients screened, 100% screened positive for at least one symptom, 100% of eligible patients consented, and eight (of 10) completed the intervention (mean age 59 years, 50% male, 50% African American). Patient adherence and satisfaction was high, and seven of the eight patients completed all eight prescribed sessions. Minimal interference with HD was reported. Preliminary results indicate no statistically significant changes in depression, fatigue, or pain at follow-up. However, there was small improvement in SF-36 Physical Component score [t(7) = -2.60, p = .035], and four of the six patients (67%) with clinically elevated pain at baseline reported improvement at follow-up. A technology-assisted CBT intervention for ESRD patients was feasible, well-accepted, and required minimal additional resources in the HD setting. Larger, adequately powered clinical trials are needed to evaluate the effect on ESRD patient-reported outcomes.
技术辅助认知行为疗法(CBT)干预已针对包括慢性疾病患者的抑郁、疼痛和疲劳在内的症状进行了研究,但尚未针对终末期肾病(ESRD)患者进行研究。本研究的目的是在接受血液透析(HD)的 ESRD 患者中尝试进行技术辅助 CBT 干预的可行性和可接受性,分享设计和实施过程中的经验教训,并提供选择患者报告症状变化的初步结果。这是一项针对接受 HD 的成年 ESRD 患者的单中心试点可行性研究。研究纳入标准要求至少有一种症状(抑郁、疼痛或疲劳)的临床水平升高。患者在接受 HD 治疗期间,每周与 CBT 治疗师通过视频会议平台会面 8 次,每次 45-60 分钟。在基线和 3 个月随访时完成症状问卷。在筛选的 10 名患者中,有 100%的患者至少有一种症状筛查阳性,100%符合条件的患者同意参加研究,有 8 名(10 名中的 8 名)患者完成了干预(平均年龄 59 岁,50%为男性,50%为非裔美国人)。患者的依从性和满意度较高,8 名患者中有 7 名完成了所有 8 次规定的治疗。报告称 HD 治疗基本不受干扰。初步结果表明,在随访时,抑郁、疲劳或疼痛均无统计学意义上的显著变化。然而,SF-36 生理成分评分[ t (7) = -2.60,p =.035]略有改善,且基线时疼痛水平升高的 6 名患者中有 4 名(67%)在随访时报告疼痛有所改善。在 HD 环境中,针对 ESRD 患者的技术辅助 CBT 干预是可行的,患者接受程度高,所需额外资源很少。需要进行更大规模、充分有力的临床试验,以评估其对 ESRD 患者报告结局的影响。